A nonhuman primate toxicology and immunogenicity study evaluating aerosol delivery of AERAS-402/Ad35 vaccine-Reference-Cited by-同舟云学术

A nonhuman primate toxicology and immunogenicity study evaluating aerosol delivery of AERAS-402/Ad35 vaccine

Published:2014-05-08 Issue:8 Volume:10 Page:2199-2210
ISSN:2164-5515
Container-title:Human Vaccines & Immunotherapeutics
language:en
Short-container-title:Human Vaccines & Immunotherapeutics

Author:

Hokey David A,Wachholder Robert,Darrah Patricia A,Bolton Diane L,Barouch Dan H,Hill Krystal,Dheenadhayalan Veerabadran,Schwander Stephan,Godin C Steven,Douoguih Macaya,Pau Maria Grazia,Seder Robert A,Roederer Mario,Sadoff Jerald C,Sizemore Donata

Publisher

Informa UK Limited

Subject

Pharmacology,Immunology,Immunology and Allergy

Link

http://www.tandfonline.com/doi/pdf/10.4161/hv.29108

Reference52 articles.

1. The success and failure of BCG — implications for a novel tuberculosis vaccine

2. Tuberculosis vaccine research: the impact of immunology

3. Protective Effect of BCG against Tuberculous Meningitis and Miliary Tuberculosis: A Meta-Analysis

4. Effect of BCG vaccination on childhood tuberculous meningitis and miliary tuberculosis worldwide: a meta-analysis and assessment of cost-effectiveness

5. Protection by BCG Vaccine Against Tuberculosis: A Systematic Review of Randomized Controlled Trials

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mucosal adenovirus vaccine boosting elicits IgA and durably prevents XBB.1.16 infection in nonhuman primates;Nature Immunology;2024-09-03

2. Immunopharmacology and Immunotoxicology Assessment of Vaccines and Adjuvants;Reference Module in Biomedical Sciences;2024

3. Mucosal Adenoviral-vectored Vaccine Boosting Durably Prevents XBB.1.16 Infection in Nonhuman Primates;2023-11-08

4. Intravenous BCG Vaccination of Diversity Outbred Mice Results in Moderately Enhanced Protection against Challenge with Mycobacterium tuberculosis Compared to Intradermal Vaccination;Infection and Immunity;2023-07-18

5. Tuberculosis control by novel vaccines development and Indian initiatives;MGM Journal of Medical Sciences;2023